A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression ...
Researchers all over the world are actively seeking treatments or a cure for Alzheimer’s disease — a form of dementia currently impacting about 32 million people globally. The medications used right ...
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study. A new drug strategy that ...
Scientists at Gladstone Institutes and UCSF have turned to computational shortcuts to find Alzheimer’s treatments among drugs ...
Combination strategies and switching therapies offer alternatives when monotherapy for alopecia areata is ineffective, addressing limited efficacy and side effects of traditional treatments. JAK ...
Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with certain subtypes of acute myeloid leukemia (AML). Subscribe to our newsletter ...
Using CRISPR gene editing, Kathleen Mulvaney (center), an assistant professor with the Fralin Biomedical Research Institute, revealed a combination of therapies that showed promise in treating cancer ...
With drug and device development following different tracks and timelines, it's critical to take vital considerations into ...
Generic combination drug product applications (Abbreviated New Drug Applications-ANDA) are rapidly increasing, driven by the rise of GLP-1 drugs. In this one-hour webcast, you'll receive detailed ...